Ávila, M.; Prado, M.d.C.; Romero, R.; Córdova, R.; Rigo, M.d.C.; Trejo, M.; Mora, C.; Paniagua, R.; for the Mexican Nephrology Collaborative Study Group.
Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis. Biomolecules 2022, 12, 551.
https://doi.org/10.3390/biom12040551
AMA Style
Ávila M, Prado MdC, Romero R, Córdova R, Rigo MdC, Trejo M, Mora C, Paniagua R, for the Mexican Nephrology Collaborative Study Group.
Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis. Biomolecules. 2022; 12(4):551.
https://doi.org/10.3390/biom12040551
Chicago/Turabian Style
Ávila, Marcela, Ma. del Carmen Prado, Renata Romero, Ricardo Córdova, Ma. del Carmen Rigo, Miguel Trejo, Carmen Mora, Ramón Paniagua, and for the Mexican Nephrology Collaborative Study Group.
2022. "Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis" Biomolecules 12, no. 4: 551.
https://doi.org/10.3390/biom12040551
APA Style
Ávila, M., Prado, M. d. C., Romero, R., Córdova, R., Rigo, M. d. C., Trejo, M., Mora, C., Paniagua, R., & for the Mexican Nephrology Collaborative Study Group.
(2022). Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis. Biomolecules, 12(4), 551.
https://doi.org/10.3390/biom12040551